A rating of 43 puts Pacific Biosciences of California Inc (PACB) near the top of the Healthcare sector according to InvestorsObserver. Pacific Biosciences of California Inc’s score of 43 means that it ranks higher than 43% of stocks in the sector. In addition, its overall score of 37 ranks it higher than 37% of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What’s Happening With Pacific Biosciences of California Inc Stock Today?
Pacific Biosciences of California Inc (PACB) stock is trading at $11.25 as of 12:24 PM on Tuesday, Nov 15, an increase of $1.12, or 11.06% from the previous closing price of $10.13. The stock has traded between $11.04 and $12.37 so far today. Volume today is 5,024,526 compared to average volume of 6,356,010. Click Here to get the full Stock Report for Pacific Biosciences of California Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.